x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
¨
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
Delaware
|
20-5657551
|
|
(State or other jurisdiction of incorporation of organization)
|
(I.R.S. Employer Identification Number)
|
Page
|
||
PART
I.
|
FINANCIAL
INFORMATION
|
|
Item
1.
|
Financial
Statements (Unaudited)
|
|
Condensed
Consolidated Balance Sheets as of June 30, 2008 and December 31,
2007
|
1
|
|
Condensed
Consolidated Statements of Income for the Three and Six- Month Periods
Ended June 30, 2008 and 2007
|
2
|
|
Condensed
Consolidated Statements of Cash Flows for the Six- Month Periods
Ended
June 30, 2008 and 2007
|
3
|
|
Notes
to Condensed Consolidated Financial Statements
|
4
|
|
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
12
|
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
14
|
Item
4.
|
Controls
and Procedures
|
14
|
PART
II.
|
OTHER
INFORMATION
|
|
Item
1.
|
Legal
Proceedings
|
15
|
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
15
|
Item
3.
|
Defaults
upon Senior Securities
|
15
|
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
15
|
Item
5.
|
Other
Information
|
15
|
Item
6.
|
Exhibits
|
16
|
SIGNATURES
|
17
|
June 30,
2008
|
December 31,
2007
|
||||||
(Unaudited)
|
(Note B)
|
||||||
Assets
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
28,959
|
$
|
30,473
|
|||
Short-term
investments
|
-
|
1,998
|
|||||
Accounts
receivable, net of allowances for doubtful accounts of $87 and
$150
|
25,929
|
31,856
|
|||||
Inventories
|
667
|
186
|
|||||
Deferred
income taxes
|
666
|
1,589
|
|||||
Prepaid
expenses and other current assets
|
2,766
|
1,761
|
|||||
Total
current assets
|
58,987
|
67,863
|
|||||
Property
and equipment, net of accumulated depreciation of $11,340 and $10,091,
respectively
|
17,538
|
11,302
|
|||||
Goodwill
|
2,119
|
2,119
|
|||||
Other
intangible assets, net of accumulated amortization of $1,385 and
$1,320,
respectively
|
1,345
|
1,088
|
|||||
Deferred
income taxes
|
3,577
|
2,552
|
|||||
Other
assets
|
2,847
|
2,290
|
|||||
Total
assets
|
$
|
86,413
|
$
|
87,214
|
|||
Liabilities
and Shareholders’ Equity
|
|||||||
Current
liabilities:
|
|||||||
Short-term
debt
|
$
|
2,183
|
$
|
2,051
|
|||
Accounts
payable
|
9,648
|
13,632
|
|||||
Accrued
liabilities
|
3,956
|
7,037
|
|||||
Total
current liabilities
|
15,787
|
22,720
|
|||||
Other
liabilities
|
1,326
|
1,255
|
|||||
Total
liabilities
|
17,113
|
23,975
|
|||||
Shareholders'
equity:
|
|||||||
Common
stock, $.01 par value, 40,000,000 shares authorized, 23,971,622 and
22,410,064 shares issued, respectively
|
239
|
224
|
|||||
Additional
paid-in capital
|
115,316
|
111,459
|
|||||
Accumulated
deficit
|
(46,802
|
)
|
(48,882
|
)
|
|||
Accumulated
other comprehensive income
|
275
|
166
|
|||||
Nil
coupon perpetual loan notes
|
272
|
272
|
|||||
Total
shareholders' equity
|
69,300
|
63,239
|
|||||
Total
liabilities and shareholders' equity
|
$
|
86,413
|
$
|
87,214
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
||||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
Revenues
|
$
|
18,791
|
$
|
16,210
|
$
|
39,258
|
$
|
32,472
|
|||||
Costs
and expenses:
|
|||||||||||||
Cost
of sales
|
9,833
|
9,083
|
20,502
|
18,040
|
|||||||||
Selling,
general and administrative
|
7,413
|
6,563
|
14,392
|
12,469
|
|||||||||
Research
and development
|
909
|
557
|
1,464
|
1,111
|
|||||||||
18,155
|
16,203
|
36,358
|
31,620
|
||||||||||
Operating
income
|
636
|
7
|
2,900
|
852
|
|||||||||
Interest
expense
|
(16
|
)
|
-
|
(62
|
)
|
-
|
|||||||
Interest
income
|
189
|
419
|
465
|
836
|
|||||||||
Other
(expense) income
|
(52
|
)
|
(30
|
)
|
84
|
(71
|
)
|
||||||
Income
before taxes
|
757
|
396
|
3,387
|
1,617
|
|||||||||
Income
tax expense
|
(310
|
)
|
(114
|
)
|
(1,307
|
)
|
(543
|
)
|
|||||
Net
income
|
$
|
447
|
$
|
282
|
$
|
2,080
|
$
|
1,074
|
|||||
Net
income per Common Share:
|
|||||||||||||
Basic
|
$
|
0.02
|
$
|
0.01
|
$
|
0.09
|
$
|
0.05
|
|||||
Diluted
|
$
|
0.02
|
$
|
0.01
|
$
|
0.08
|
$
|
0.04
|
|||||
Weighted-average
number of Common Shares outstanding:
|
|||||||||||||
Basic
|
23,951,000
|
22,220,000
|
23,186,000
|
22,164,000
|
|||||||||
Diluted
|
24,698,000
|
24,679,000
|
24,589,000
|
24,666,000
|
Six Months Ended
June 30,
|
|||||||
2008
|
2007
|
||||||
Operating
activities
|
|||||||
Net
cash provided by (used in) operating activities
|
$
|
3,307
|
$
|
(1,062
|
)
|
||
Investing
activities
|
|||||||
Sales
of short-term investments
|
1,998
|
8,000
|
|||||
Purchases
of property, equipment and intangible assets
|
(7,819
|
)
|
(2,028
|
)
|
|||
Net
cash (used in) provided by investing activities
|
(5,821
|
)
|
5,972
|
||||
Financing
activities
|
|||||||
Proceeds
from short-term borrowings
|
132
|
-
|
|||||
Issuance
of deferred shares
|
36
|
1,110
|
|||||
Proceeds
from exercise of stock options and warrants
|
331
|
785
|
|||||
Excess
tax benefit for stock-based compensation
|
392
|
1,379
|
|||||
Net
cash provided by financing activities
|
891
|
3,274
|
|||||
Effect
of exchange rate fluctuations on cash
|
109
|
15
|
|||||
Net
(decrease) increase in cash and cash equivalents
|
(1,514
|
)
|
8,199
|
||||
Cash
and cash equivalents at beginning of period
|
30,473
|
24,405
|
|||||
Cash
and cash equivalents at end of period
|
$
|
28,959
|
$
|
32,604
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
||||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
Basic
weighted-average shares
|
23,951
|
22,220
|
23,186
|
22,164
|
|||||||||
Conversion
of unsecured loan notes
|
45
|
45
|
45
|
45
|
|||||||||
Unexercised
options and warrants
|
702
|
2,414
|
1,358
|
2,457
|
|||||||||
Diluted
weighted-average shares
|
24,698
|
24,679
|
24,589
|
24,666
|
Three Months Ended
June 30,
|
|
Six Months Ended
June 30,
|
|||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
Comprehensive
income:
|
|||||||||||||
Net
income
|
$
|
447
|
$
|
282
|
$
|
2,080
|
$
|
1,074
|
|||||
Foreign
currency translation
|
18
|
12
|
109
|
15
|
|||||||||
$
|
465
|
$
|
294
|
$
|
2,189
|
$
|
1,089
|
2008
|
2007
|
||||||
Expected
dividend yield
|
0.00
|
%
|
0.00
|
%
|
|||
Risk-free
interest rate
|
2.97
|
%
|
4.78
|
%
|
|||
Expected
volatility
|
58.4
|
%
|
56.9
|
%
|
|||
Expected
life of option
|
5.2
years
|
5.1
years
|
Number
of
Options
|
Weighted-
Average
Exercise
Price
|
Weighted-
Average
Remaining
Contractual
Term
|
Aggregate
Intrinsic
Value
|
||||||||||
Outstanding on January 1, 2008
|
2,464,325
|
$
|
15.03
|
||||||||||
Granted
|
626,500
|
19.16
|
|||||||||||
Exercised
|
(75,625
|
)
|
4.38
|
$
|
1,224
|
||||||||
Expired
or forfeited
|
(31,250
|
)
|
24.04
|
||||||||||
Outstanding
on June 30, 2008
|
2,983,950
|
$
|
16.07
|
7.81
years
|
$
|
15,157
|
|||||||
Exercisable
on June 30, 2008
|
1,063,825
|
$
|
8.84
|
6.27
years
|
$
|
11,039
|
|||||||
Weighted-average
fair value of options granted during first six months of
2008
|
$
|
10.20
|
Nonvested Stock
Outstanding
|
||||
Outstanding
on January 1, 2008
|
1,508,500
|
|||
Granted
|
626,500
|
|||
Released
|
(183,625
|
)
|
||
Expired
or forfeited
|
(31,250
|
)
|
||
Outstanding
on June 30, 2008
|
1,920,125
|
Three months ended
June 30, 2008
|
Nitrogen Oxide
Reduction
|
Fuel Treatment
Chemical
|
Other
|
Total
|
|||||||||
Revenues from external customers
|
$
|
10,477
|
$
|
8,314
|
$
|
-
|
$
|
18,791
|
|||||
Cost
of sales
|
5,658
|
4,174
|
1
|
9,833
|
|||||||||
Gross
margin
|
4,819
|
4,140
|
(1
|
)
|
8,958
|
||||||||
Selling,
general and administrative
|
-
|
-
|
7,413
|
7,413
|
|||||||||
Research
and development
|
-
|
-
|
909
|
909
|
|||||||||
Operating
income (loss)
|
$
|
4,819
|
$
|
4,140
|
$
|
(8,323
|
)
|
$
|
636
|
Three months ended
June 30, 2007
|
Nitrogen Oxide
Reduction
|
Fuel Treatment
Chemical
|
Other
|
Total
|
|||||||||
Revenues from external customers
|
$
|
7,648
|
$
|
8,562
|
$
|
-
|
$
|
16,210
|
|||||
Cost
of sales
|
4,745
|
4,304
|
34
|
9,083
|
|||||||||
Gross
margin
|
2,903
|
4,258
|
(34
|
)
|
7,127
|
||||||||
Selling,
general and administrative
|
-
|
-
|
6,563
|
6,563
|
|||||||||
Research
and development
|
-
|
-
|
557
|
557
|
|||||||||
Operating
income (loss)
|
$
|
2,903
|
$
|
4,258
|
$
|
(7,154
|
)
|
$
|
7
|
Six months ended
June 30, 2008
|
Nitrogen Oxide
Reduction
|
Fuel Treatment
Chemical
|
Other
|
Total
|
|||||||||
Revenues from external customers
|
$
|
22,146
|
$
|
17,112
|
$
|
-
|
$
|
39,258
|
|||||
Cost
of sales
|
11,803
|
8,698
|
1
|
20,502
|
|||||||||
Gross
margin
|
10,343
|
8,414
|
(1
|
)
|
18,756
|
||||||||
Selling,
general and administrative
|
-
|
-
|
14,392
|
14,392
|
|||||||||
Research
and development
|
-
|
-
|
1,464
|
1,464
|
|||||||||
Operating
income (loss)
|
$
|
10,343
|
$
|
8,414
|
$
|
(15,857
|
)
|
$
|
2,900
|
Six months ended
June 30, 2007
|
Nitrogen Oxide
Reduction
|
Fuel Treatment
Chemical
|
Other
|
Total
|
|||||||||
Revenues from external customers
|
$
|
16,257
|
$
|
16,215
|
$
|
-
|
$
|
32,472
|
|||||
Cost
of sales
|
9,772
|
8,199
|
69
|
18,040
|
|||||||||
Gross
margin
|
6,485
|
8,016
|
(69
|
)
|
14,432
|
||||||||
Selling,
general and administrative
|
-
|
-
|
12,469
|
12,469
|
|||||||||
Research
and development
|
-
|
-
|
1,111
|
1,111
|
|||||||||
Operating
income (loss)
|
$
|
6,485
|
$
|
8,016
|
$
|
(13,649
|
)
|
$
|
852
|
Three months ended June 30,
|
Six months ended June 30,
|
||||||||||||
2008
|
2007
|
2008
|
2007
|
||||||||||
Revenues:
|
|||||||||||||
United
States
|
$
|
16,442
|
$
|
11,584
|
$
|
35,526
|
$
|
25,591
|
|||||
Foreign
|
2,349
|
4,626
|
3,732
|
6,881
|
|||||||||
$
|
18,791
|
$
|
16,210
|
$
|
39,258
|
$
|
32,472
|
June 30,
2008
|
December 31,
2007
|
||||||
Assets:
|
|||||||
United
States
|
$
|
79,254
|
$
|
79,132
|
|||
Foreign
|
7,159
|
8,082
|
|||||
$
|
86,413
|
$
|
87,214
|
2008
|
||||
Aggregate
product warranty liability at January 1, 2008
|
$
|
464
|
||
Aggregate
accruals related to product warranties
|
30
|
|||
Aggregate
reductions for payments
|
(143
|
)
|
||
Aggregate
product warranty liability at June 30, 2008
|
$
|
351
|
·
|
Level
1 – Unadjusted quoted prices in active markets that are accessible at
the measurement date for identical, unrestricted assets or
liabilities.
|
·
|
Level
2 – Inputs other than quoted prices included within Level 1 that are
observable for the asset or liability, either directly or indirectly,
including quoted prices for similar assets or liabilities in active
markets; quoted prices for identical or similar assets or liabilities
in
markets that are not active; inputs other than quoted prices that
are
observable for the asset or liability (e.g., interest rates); and
inputs
that are derived principally from or corroborated by observable market
data by correlation or other means.
|
·
|
Level
3 – Inputs that are both significant to the fair value measurement and
unobservable.
|
Item 2. |
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
(in
thousands, except share and per-share
data)
|
Director
|
For
|
Withheld
|
|||||
Douglas
G. Bailey
|
13,696,741
|
820,995
|
|||||
Ralph
E. Bailey
|
13,805,504
|
712,232
|
|||||
Miguel
Espinosa
|
13,866,606
|
651,130
|
|||||
Charles
W. Grinnell
|
13,631,669
|
886,067
|
|||||
Thomas
L. Jones
|
13,833,502
|
684,234
|
|||||
John
D. Morrow
|
13,823,543
|
694,193
|
|||||
John
F. Norris Jr.
|
13,806,451
|
711,285
|
|||||
Thomas
S. Shaw, Jr.
|
13,757,809
|
759,927
|
|||||
D.L.
Williamson
|
13,833,297
|
684,449
|
For
|
Against
|
Abstain
|
|||||
14,299,628
|
173,599
|
44,509
|
By:
|
/s/
John F. Norris Jr.
|
|
John F. Norris Jr.
|
||
Director,
President
and
Chief
Executive Officer
|
||
Date:
August 11, 2008
|
By:
|
/s/
John P. Graham
|
John P. Graham
|
||
Chief Financial Officer,
|
||
Sr. Vice President and
|
||
Treasurer
|